Patents by Inventor John D. Catt

John D. Catt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
    Patent number: 6777437
    Abstract: The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts or solvates thereof and pharmaceutically acceptable formulations comprising said compounds useful for the treatment of depression, anxiety disorders, premature ejaculation, chronic pain, obsessive-compulsive disorder, feeding disorders, premenstrual dysphoric disorder, panic disorders and psychotic disorders including bipolar disorder and schizophrenia.
    Type: Grant
    Filed: March 5, 2002
    Date of Patent: August 17, 2004
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ronald J. Mattson, Derek John Denhart, Jeffrey A. Deskus, Jonathan L. Ditta, Lawrence R. Marcin, James R. Epperson, John D. Catt, Dalton King, Mendi A. Higgins
  • Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
    Publication number: 20030073849
    Abstract: The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts or solvates thereof and pharmaceutically acceptable formulations comprising said compounds 1
    Type: Application
    Filed: March 5, 2002
    Publication date: April 17, 2003
    Inventors: Ronald J. Mattson, Derek John Denhart, Jeffrey A. Deskus, Jonathan L. Ditta, Lawrence R. Marcin, James R. Epperson, John D. Catt, Dalton King, Mendi A. Higgins
  • Piperazinyl-cyclohexanes and cyclohexenes
    Patent number: 6153611
    Abstract: Novel non-dopaminergic antiischemic compounds have Formula I: ##STR1## wherein R=R.sub.1 and is independently H, C.sub.1-4 alky C.sub.1-4 alkoxy, C.sub.1-4 trihaloalkyl or halogen, or R and R.sub.1 may be taken together to form an --O(CH.sub.2).sub.m O-- (m=1 or 2);X=a 3-indolyl, phenyl, naphthalenyl or 2-benzothiazolyl residue;n=0, 1, 2 or 3; ##STR2## R.sub.2 =R.sub.3 and is independently H or C.sub.1-4 alkyl; and R.sub.4 =phenyl, 2-thienyl, 2-quinolinyl, 4-pyridinyl or substituted phenyl.
    Type: Grant
    Filed: June 25, 1993
    Date of Patent: November 28, 2000
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ronald J. Mattson, John D. Catt
  • Benzopyran derivatives as melatonergic agents
    Patent number: 6060506
    Abstract: Novel derivatives of benzopyran are provided which are useful as melatonergic agents.
    Type: Grant
    Filed: July 13, 1999
    Date of Patent: May 9, 2000
    Assignee: Bristol-Myers Squibb Company
    Inventors: John D. Catt, Graham Johnson, Daniel J. Keavy, Ronald J. Mattson, Michael F. Parker, Katherine S. Takaki, Joseph P. Yevich
  • Benzodioxa alkylene ethers as melatonergic agents
    Patent number: 5981571
    Abstract: Novel derivatives of benzodioxa alkylene ethers are provided which are useful as melatonergic agents.
    Type: Grant
    Filed: October 9, 1998
    Date of Patent: November 9, 1999
    Assignee: Bristol-Myers Squibb Company
    Inventors: John D. Catt, Graham Johnson, Daniel J. Keavy, Ronald J. Mattson, Michael F. Parker, Katherine S. Takaki, Joseph P. Yevich
  • Benzofuran and dihydrobenzofuran melatonergic agents
    Patent number: 5856529
    Abstract: Novel derivatives of benzofuran and dihydrobenzofuran are provided which are useful as melatonergic agents.
    Type: Grant
    Filed: December 9, 1997
    Date of Patent: January 5, 1999
    Assignee: Bristol-Myers Squibb Company
    Inventors: John D. Catt, Graham Johnson, Daniel J. Keavy, Ronald J. Mattson, Michael F. Parker, Katherine S. Takaki, Joseph P. Yevich
  • Melatonergic indanyl piperazines
    Patent number: 5780470
    Abstract: Certain indanyl piperazines are useful as melatonergic agents and can treat various CNS disorders. They are use useful in treating sleep disorders and other conditions related to circadian rhythms.
    Type: Grant
    Filed: April 18, 1996
    Date of Patent: July 14, 1998
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ronald J. Mattson, John D. Catt
  • Indanylpiperidines as melatonergic agents
    Patent number: 5703239
    Abstract: Certain indanyl piperidines are useful as melatonergic agents and can treat various CNS disorders. They are useful in treating sleep disorders and other conditions related to circadian rhythms.
    Type: Grant
    Filed: April 16, 1996
    Date of Patent: December 30, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ronald J. Mattson, John D. Catt
  • Aminomethyl-benzodioxane and benzopyran serotonergic agents
    Patent number: 5658941
    Abstract: Certain aminomethyl-benzodioxanes and benzopyrans are useful serotonergic agents. They possess anxiolytic properties with few of the side effects often associated with dopaminergic agents.
    Type: Grant
    Filed: December 13, 1995
    Date of Patent: August 19, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: John D. Catt, Ronald J. Mattson
  • Antischemic piperazinyl- and piperidinyl-cyclohexanes
    Patent number: 5595993
    Abstract: Piperidinyl-substituted cyclohexanes of Formula I have anti-ischemic properties: ##STR1## wherein R=R.sub.1 and is independently H or halogen; or R and R.sub.1 may be taken together to form an --O(CH.sub.2).sub.m O-- (m=1 or 2);X=a phenyl residue;R.sub.2 =R.sub.3 and is independently H or C.sub.1-4 alkyl; andR.sub.4 =phenyl or substituted phenyl wherein the phenyl group is mono-, or di-substituted with groups selected from: F, Cl, I and C.sub.1-4 alkoxy.
    Type: Grant
    Filed: September 14, 1994
    Date of Patent: January 21, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ronald J. Mattson, John D. Catt
  • 3-alkoxybenzylpiperidine derivatives as melatonergic agents
    Patent number: 5530012
    Abstract: Novel 3-alkoxybenzylpiperidines have melatonergic properties. They are believed useful in treating depression, jet-lag, work-shift syndrome, sleep disorders, glaucoma, some disorders associated with reproduction, cancer, immune disorders and neuroendocrine disorders.
    Type: Grant
    Filed: December 22, 1994
    Date of Patent: June 25, 1996
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Ronald J. Mattson, John D. Catt, Daniel J. Keavy
  • Aminomethyl-benzodioxane and benzopyran serotonergic agents
    Patent number: 5496847
    Abstract: Certain aminomethyl-benzodioxanes and benzopyrans are useful serotonergic agents. They possess anxiolytic properties with few of the side effects often associated with dopaminergic agents.
    Type: Grant
    Filed: January 24, 1995
    Date of Patent: March 5, 1996
    Assignee: Bristol-Myers Squibb Co.
    Inventors: John D. Catt, Ronald J. Mattson
  • Piperazinyl-and piperidinyl-cyclohexanols
    Patent number: 5478828
    Abstract: Novel piperazinyl- and piperidinyl-cyclohexanols are useful as anxiolytic agents and have other psychotropic properties.
    Type: Grant
    Filed: January 24, 1995
    Date of Patent: December 26, 1995
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ronald J. Mattson, John D. Catt
  • Aminomethyl-benzodioxane and benzopyran serotonergic agents
    Patent number: 5391570
    Abstract: Certain aminomethyl-benzodioxanes and benzopyrans are useful serotonergic agents. They possess anxiolytic properties with few of the side effects often associated with dopaminergic agents.
    Type: Grant
    Filed: October 14, 1993
    Date of Patent: February 21, 1995
    Assignee: Bristol-Myers Squibb
    Inventors: John D. Catt, Ronald J. Mattson
  • Piperazinyl-and piperidinyl-cyclohexanols
    Patent number: 5387593
    Abstract: Novel piperazinyl- and piperidinyl-cyclohexanols of the following formula are useful as anxiolytic agents and have other psychotropic properties ##STR1##
    Type: Grant
    Filed: February 17, 1994
    Date of Patent: February 7, 1995
    Assignee: Briston-Myers Squibb
    Inventors: Ronald J. Mattson, John D. Catt
  • Antiischemic piperazinyl- and piperidinyl-cyclohexanes
    Patent number: 5352678
    Abstract: Certain piperazinyl- and piperidinyl-substituted cyclohexanes have anti-ischemic properties.
    Type: Grant
    Filed: June 25, 1993
    Date of Patent: October 4, 1994
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Ronald J. Mattson, John D. Catt
  • Antihypercholesterolemic alkylene compounds
    Patent number: 5011947
    Abstract: Compounds of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 each are independently hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy or trifluoromethyl;R is C.sub.1-7 alkyl, C.sub.3-6 cycloalkyl, fluoromethyl, difluoromethyl, trifluoromethyl;A is ##STR2## R.sup.5 is hydrogen, a hydrolyzable ester group or a cation to form a non-toxic pharmaceutically acceptable salt,are novel antihypercholesterolemic agents which inhibit cholesterol biosynthesis. Intermediates and processes for their preparation are disclosed.
    Type: Grant
    Filed: June 12, 1990
    Date of Patent: April 30, 1991
    Assignee: Bristol-Myers
    Inventors: John D. Catt, John J. Wright
  • Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it
    Patent number: 4419358
    Abstract: This invention concerns an isethionic acid addition salt of the non-adrenergic bronchodilating agent 9-cyclohexyl-2-propoxy-9H-purine-6-amine. The salt is comprised of a 2:1 molecular ratio of the isethionic acid to the adenine base. The salt of the invention is characterized in having improved water solubility and stability.
    Type: Grant
    Filed: November 12, 1981
    Date of Patent: December 6, 1983
    Assignee: Mead Johnson & Company
    Inventors: John D. Catt, Davis L. Temple, Jr.
  • Sulfamidophenethanolamine therapeutic process
    Patent number: 4044151
    Abstract: para-Sulfamidophenethanolamines are prepared from para-sulfamidophenacyl halides. The phenethanolamines have useful beta-adrenergic blocking action.
    Type: Grant
    Filed: November 19, 1975
    Date of Patent: August 23, 1977
    Assignee: Mead Johnson & Company
    Inventors: William T. Comer, John D. Catt